Camp4 Therapeutics Grants 8,000 Stock Options to New Employee

Camp4 Therapeutics announced that its Compensation Committee granted a non-qualified stock option to purchase 8,000 shares of common stock to a newly hired employee on July 15, 2026. This inducement grant, made under Nasdaq Listing Rule 5635(c)(4), has an exercise price of $4.21 per share, equal to the closing price on the grant date. The option will vest over a four-year period, with 25% vesting on the one-year anniversary and the remainder in 36 equal monthly installments, subject to continued employment.